About EnteroMedics
EnteroMedics is a company based in Saint Paul (United States) founded in 2002. EnteroMedics has raised $62.1 million across 9 funding rounds from investors including InterWest, ONSET Ventures and Pacific Asset Partners. The company has 63 employees as of December 31, 2020. EnteroMedics has completed 3 acquisitions, including BarioSurg, ReShape and ReShape Lifesciences. EnteroMedics operates in a competitive market with competitors including Aspire Bariatrics, Elira, Endosphere, Melcap Systems and MelCap Systems, among others.
- Headquarter Saint Paul, United States
- Employees 63 as on 31 Dec, 2020
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Enteromedics Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of EnteroMedics
Unlock access to complete
Unlock access to complete
Funding Insights of EnteroMedics
EnteroMedics has successfully raised a total of $62.1M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $61 million completed in October 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EnteroMedics
EnteroMedics has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include InterWest, ONSET Ventures and Pacific Asset Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investing in IT and healthcare ventures.
|
Locked | Locked | Locked | |
|
Early stage VC firm investing in the US
|
Locked | Locked | Locked | |
|
Stage-agnostic investments in US life-sciences sectors are managed.
|
Locked | Locked | Locked |
Investor details for EnteroMedics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EnteroMedics
EnteroMedics has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include BarioSurg, ReShape and ReShape Lifesciences.
Investment portfolio details for EnteroMedics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Minimally invasive devices for obesity and metabolic treatment are developed.
|
Locked | Locked | 2009 | Locked | |
|
A dual intra-gastric balloon system is provided for weight loss.
|
Locked | Locked | 2005 | Locked | |
|
Patented minimally invasive technologies are developed for cartilage malformation corrections.
|
Locked | Locked | 2002 | Locked |
Complete acquisition details for EnteroMedics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - EnteroMedics
Detailed financials for EnteroMedics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Enteromedics Comparisons
Peer comparison for EnteroMedics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EnteroMedics
EnteroMedics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aspire Bariatrics, Elira, Endosphere, Melcap Systems and MelCap Systems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Aspire Bariatrics is focused on weight loss solutions.
|
|
| Locked | Locked | Locked |
Wearable neurostimulation devices for appetite suppression are developed by Elira.
|
|
| Locked | Locked | Locked |
Provides a duodenal insertable implant for effective obesity treatment.
|
|
| Locked | Locked | Locked |
Develops wireless ingestible capsules and apps for non-invasive weight management solutions.
|
|
| Locked | Locked | Locked |
Develops swallowable capsules for non-invasive obesity treatment and global health solutions.
|
Detailed competitors of EnteroMedics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Enteromedics
Complete news archive for EnteroMedics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EnteroMedics
EnteroMedics was founded in 2002 and raised its 1st funding round 2 years after it was founded.
EnteroMedics is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.
EnteroMedics is a funded company, having raised a total of $62.1M across 9 funding rounds to date.
As of Dec 31, 2020, the latest employee count at EnteroMedics is 63.
EnteroMedics has developed VBLOC vagal blocking therapy, a patented therapeutic approach designed to treat a range of gastrointestinal and metabolic diseases. vBloc Therapy is delivered by a pacemaker-like device called the Maestro Rechargeable System that decreases feelings of hunger and fullness by limiting the expansion of the stomach and by reducing the frequency and intensity of stomach contractions. This is achieved by intermittently blocking the primary nerve which carries signals between the brain and stomach to regulate digestive processes. Bloc Therapy involves a minimally invasive laparoscopic procedure that preserves normal digestive system anatomy.
EnteroMedics's top competitors include Elira, Aspire Bariatrics and Endosphere.
EnteroMedics has made 3 acquisitions, including BarioSurg, ReShape, and ReShape Lifesciences.
EnteroMedics has 8 investors. Key investors include InterWest, ONSET Ventures, Pacific Asset Partners, Bay City Capital, and Turmeric Acquisition Corp.